HOOK (HOOKIPA Pharma) Float Percentage Of Total Shares Outstanding: 65.43% (As of Jun. 29, 2026)


HOOK HOOKIPA Pharma Inc HOOK
50 GF Score
Price $1.15
GF Value $2.78
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is HOOKIPA Pharma Float Percentage Of Total Shares Outstanding?

HOOKIPA Pharma HOOK 50 Float Percentage Of Total Shares Outstanding is 65.43% as of Jun. 29, 2026. GuruFocus rates HOOK with a GF Score™ of 50/100 and a GF Value™ of $2.78 (Possible Value Trap). The stock has 7 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, HOOKIPA Pharma's float shares is 8.10 Mil. HOOKIPA Pharma's total shares outstanding is 12.38 Mil. HOOKIPA Pharma's float percentage of total shares outstanding is 65.43%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, HOOKIPA Pharma's Insider Ownership is 4.60%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, HOOKIPA Pharma's Institutional Ownership is 7.24%.

HOOK
50GF Score
HOOKIPA Pharma Inc HOOK
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HOOKIPA Pharma Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

HOOKIPA Pharma's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=8.10/12.38
=65.43%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 65.43% mean?
HOOKIPA Pharma (HOOK) has a Float Percentage Of Total Shares Outstanding of 65.43% as of Jun. 29, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on HOOKIPA Pharma and its competitors.
Is HOOKIPA Pharma's Float Percentage Of Total Shares Outstanding too high?
HOOKIPA Pharma's current Float Percentage Of Total Shares Outstanding is 65.43%. Overall, HOOKIPA Pharma has a GF Score™ of 50/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does HOOKIPA Pharma's Float Percentage Of Total Shares Outstanding compare to COCP and LNAI?
HOOKIPA Pharma's Float Percentage Of Total Shares Outstanding of 65.43% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on HOOKIPA Pharma and its competitors. HOOKIPA Pharma's current Float Percentage Of Total Shares Outstanding is 65.43%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HOOKIPA Pharma stock overvalued right now?
Based on GuruFocus' analysis, HOOKIPA Pharma (HOOK) is currently considered Possible Value Trap. The stock's GF Value™ is $2.78, compared to a current price of $1.15 — trading 58.6% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 65.43%. HOOKIPA Pharma's overall GF Score™ is 50/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For HOOKIPA Pharma (HOOK), the current Float Percentage Of Total Shares Outstanding is 65.43% as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HOOKIPA Pharma (HOOK) Overvalued in 2026?

Based on GuruFocus' analysis, HOOKIPA Pharma stock appears to be undervalued. The current stock price of $1.15 is trading 58.6% below its estimated GF Value™ of $2.78. GuruFocus considers HOOKIPA Pharma to be Possible Value Trap.

Key valuation signals for HOOK:

  • Float Percentage Of Total Shares Outstanding: 65.43%
  • GF Value™: $2.78 vs. price of $1.15 (58.6% below fair value)
  • GF Score™: 50/100 with 7 warning signs

No single metric tells the full story. See the HOOK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HOOKIPA Pharma Business Description

Address 350 Fifth Avenue, 72nd Floor, Suite 7240, New York, NY, USA, 10118
HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. The company's product candidates are designed to induce specific, robust and durable CD8+ T cells and antibodies to eliminate cancers and serious infectious diseases. Its pipeline includes biological therapies for oncology, targeting human papillomavirus type 16-positive (HPV16+) cancers, KRAS mutated cancers, and other targets. In addition, It is also focused to develop therapies that are intended to provide functional cures for hepatitis B virus (HBV) and human immunodeficiency virus-1 (HIV-1).
50GF Score

Get the complete analysis for HOOK

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.15
Price
$2.78
GF Value